Search

Your search keyword '"Smith, Stephen D. A."' showing total 1,373 results

Search Constraints

Start Over You searched for: Author "Smith, Stephen D. A." Remove constraint Author: "Smith, Stephen D. A."
1,373 results on '"Smith, Stephen D. A."'

Search Results

2. Some results on Quillen's Conjecture via equivalent-poset techniques

3. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

5. Eliminating components in Quillen's Conjecture

7. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

8. Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

9. Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

15. Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

23. Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

24. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

25. HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

26. Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

29. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

31. Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors

37. Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

42. Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study

43. Acalabrutinib in Combination with Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Lymphoma: A Phase I/II Study of Safety, Efficacy and Immune Correlative Analysis

45. Geo-temporal patterns to design cost-effective interventions for zoonotic diseases -the case of brucellosis in the country of Georgia

46. Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

49. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

50. 1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs)

Catalog

Books, media, physical & digital resources